A phase I study of MEDI1873, a novel GITR agonist, in advanced solid tumors von Denlinger, C.S., Infante, J.R., Aljumaily, R., Naing, A., Chintakuntlawar, A., Rizvi, N.A., Ross, H., Gordon, M., Kumar, R., Ma, M., Yan, L., Vicini, P., Standifer, N., Cann, J., Perera, A., Durham, N., Krishnan, S., Balmanoukian, A.

Volltext

Translational endpoints in patients with metastatic microsatellite-stable colorectal cancer (MSS-CRC) treated with durvalumab plus monalizumab (anti-NKG2A) von Diamond, J.R., Standifer, N., Ascierto, M.L., Morehouse, C., Ghadially, H., Rodriguez Canales, J., Rebelatto, M.C., Naidoo, J., Mazzarella, L., Patel, S., Flor Oncala, M.J., Alonso Gordoa, T., Wang, D., Song, X., Jones, D.C., Li, X., Marshall, S., Abdullah, S., Jure-Kunkel, M., Hellmann, M.D.

Volltext

Phase I clinical and translational evaluation of AZD6738 in combination with durvalumab in patients (pts) with lung or head and neck carcinoma von Krebs, M, Lopez, J, El-Khoueiry, A, Bang, Y-J, Postel-Vinay, S, Abidah, W, Im, S-A, Khoja, L T, Standifer, N, Jones, G N, Marco-Casanova, P, Frewer, P, Berges, A, Cheung, A, Stephens, C, Felicetti, B, Dean, E, Pierce, A, Hollingsworth, S

Volltext

32P Low immunogenicity and favorable safety seen with novel regimen of tremelimumab (T) plus durvalumab (D) in patients (pts) with unresectable hepatocellular carcinoma (uHCC) von Kelley, R.K., Negro, A., Chen, C., Ali, S., Standifer, N., Watras, M., Evans, B., Abou-Alfa, G.K.

Volltext

1154PA phase I study of MEDI1873, a novel GITR agonist, in advanced solid tumors von Denlinger, C S, Infante, J R, Aljumaily, R, Naing, A, Chintakuntlawar, A, Rizvi, N A, Ross, H, Gordon, M, Kumar, R, Ma, M, Yan, L, Vicini, P, Standifer, N, Cann, J, Perera, A, Durham, N, Krishnan, S, Balmanoukian, A

Volltext

O-6 The novel regimen of tremelimumab in combination with durvalumab provides a favorable safety profile and clinical activity for patients with advanced hepatocellular carcinoma von Kelley, R., Kudo, M., Harris, W., Ikeda, M., Okusaka, T., Kang, Y., Qin, S., Tai, D., Lim, H., Yau, T., Yong, W., Cheng, A., Gasbarrini, A., de Braud, F., Bruix, J., Borad, M., Standifer, N., He, P., Negro, A., Vlahovic, G., Sangro, B., Abou-Alfa, G.

Volltext

413PDPhase I clinical and translational evaluation of AZD6738 in combination with durvalumab in patients (pts) with lung or head and neck carcinoma von Krebs, M, Lopez, J, El-Khoueiry, A, Bang, Y-J, Postel-Vinay, S, Abidah, W, Im, S-A, Khoja, L T, Standifer, N, Jones, G N, Marco-Casanova, P, Frewer, P, Berges, A, Cheung, A, Stephens, C, Felicetti, B, Dean, E, Pierce, A, Hollingsworth, S

Volltext

1194PTranslational endpoints in patients with metastatic microsatellite-stable colorectal cancer (MSS-CRC) treated with durvalumab plus monalizumab (anti-NKG2A) von Diamond, J R, Standifer, N, Ascierto, M L, Morehouse, C, Ghadially, H, Rodriguez Canales, J, Rebelatto, M C, Naidoo, J, Mazzarella, L, Patel, S, Flor Oncala, M J, Alonso Gordoa, T, Wang, D, Song, X, Jones, D C, Li, X, Marshall, S, Abdullah, S, Jure-Kunkel, M, Hellmann, M D

Volltext

A Shift in Autoreactive CD4 T Cell Avidity Preceding Diagnosis with Type 1 Diabetes is Correlated with the Outgrowth of Distinct T Cell Clonotypes von Standifer, N, Nepom, G

Volltext

Changes in autoreactive T cell avidity during type 1 diabetes development von Standifer, Nathan E, Burwell, Emily A, Gersuk, Vivian H, Greenbaum, Carla J, Nepom, Gerald T

Volltext

A hierarchy of T cell receptor motifs determines responsiveness to the immunodominant epitope in experimental autoimmune myasthenia gravis von Standifer, Nathan E., Kraig, Ellen, Infante, Anthony J.

Volltext

Longitudinal Dynamics of CD4+T Cell Responses to an Insulin Peptide in Healthy, Autoantibody-positive and Type 1 Diabetic Subjects von Standifer, N, Burwell, E, Nepom, G

Volltext

The effects of age on CD4 upregulation and Treg distribution in a TAChR peptide-specific immune response (47.1) von Stacy, Sue, Standifer, N. E., Pasquali, Amanda, Krolick, K. A., Infante, A. J., Kraig, Ellen

Volltext

Short-term Administration of Anakinra does not Appear to Affect Stimulated C-peptide Responses Acutely in Patients with Type 1 Diabetes von Sanda, S, Bollyky, J, Burwell, E, Standifer, N, Nepom, G, Greenbaum, C

Volltext

Evidence for an Increase in the Functional Avidity of the GAD-reactive CD4+ T Cell Population Prior to Diabetes Onset von Standifer, Nathan, Postdoctoral Research Associate, Benaroya Research Institute, Seattle, WA, Nepom, Gerald, Director, Benaroya Research Institute, Seattle, WA

Volltext

Restricted T cell receptor repertoire for acetylcholine receptor in murine myasthenia gravis von Kraig, Ellen, Pierce, Jessica L, Clarkin, Kimberly Z, Standifer, Nathan E, Currier, Patricia, Wall, Katherine A, Infante, Anthony J

Volltext

The effect of drying period on the germination of Eurasian watermilfoil seeds von Standifer, N E, Madsen, J D

Volltext

Cytotoxic herpes simplex type 2‐specific, DQ0602‐restricted CD4+ T‐cell clones show alloreactivity to DQ0601 von Reichstetter, Sandra, Standifer, Nathan E., Geubtner, Kelly A., Liu, Andrew W., Agar, Stacy L., Kwok, William W.

Volltext

Effect of moving, confinement to Ramadas, and Wardecker waterers on mortality of honey bees (Hymenoptera: Apidae) exposed to insecticides sprayed on cotton [Apis mellifera] von Moffett, J.O, Stoner, A, Standifer, L.N, Wardecker, A.L

Volltext

Biochemistry and microbiology of bee-collected almond (Prunus dulcis) pollen and bee bread. I. Fatty acids, sterols, vitamins and minerals von Loper, G.M, Standifer, L.N, Thompson, M.J, Gilliam, M

Volltext